← Back to news

S

Seeking Alpha: News RSS Feed

Advantage Energy GAAP EPS of $0.17 misses by $0.10, revenue of $206.92M misses by $30.78M

Eldorado Gold Non-GAAP EPS of $0.95 beats by $0.27, revenue of $532.43M beats by $25.17M

OneSpan Non-GAAP EPS of $0.39 beats by $0.04, revenue of $65.95M beats by $3.55M

Brixmor prices $400M senior notes due 2036

Delixy Holdings Limited GAAP EPS of -$0.29, revenue of $307.7M

Bayfirst Financial Corp GAAP EPS of $1.48

NMI Holdings Non-GAAP EPS of $1.28 beats by $0.05, revenue of $183.48M beats by $0.72M

Grand Canyon Education Non-GAAP EPS of $2.86 beats by $0.08, revenue of $308.76M beats by $1.16M

Ambitions Enterprise Management Co. L.L.C GAAP EPS of $0.04, revenue of $20.2M

Baiya International Group GAAP EPS of -$5.04, revenue of $16.5M

Select Medical Non-GAAP EPS of $0.36 misses by $0.10, revenue of $1.42B beats by $10M

Tanger posts beat-and-raise Q1 on record leasing volume

Warrior Met Coal GAAP EPS of $1.37 beats by $0.03, revenue of $448.47M misses by $14.8M

UMH Properties FFO of $0.23 in-line, revenue of $65.84M misses by $0.48M

Encompass Health Non-GAAP EPS of $1.60 beats by $0.11, revenue of $1.58B beats by $10M

Safehold Non-GAAP EPS of $0.40 misses by $0.04, revenue of $110.85M beats by $12.04M

Brazil Potash launches public offering of stock, pre-funded warrants

Reddit GAAP EPS of $1.01 beats by $0.45, revenue of $663.41M beats by $53.63M

Tanger FFO of $0.59 beats by $0.01, revenue of $150.42M beats by $7.6M

OrthoPediatrics GAAP EPS of -$0.45 beats by $0.04, revenue of $59.4M beats by $1.06M

Atlassian Non-GAAP EPS of $1.75 beats by $0.41, revenue of $1.79B misses by $90M

Aegon prices $500M senior notes at 5.625% coupon

Universal Display Corporation GAAP EPS of $0.76 misses by $0.39, revenue of $142.2M misses by $18.46M

Stryker Non-GAAP EPS of $2.60 misses by $0.38, revenue of $6B misses by $330M

Bristol-Myers signals 30% R&D cycle-time reduction while tracking toward upper end of 2026 guidance ranges

Franklin BSP Realty Trust signals $50M buyback capacity through Dec. 31, 2026, while integrating BSP servicing into NewPoint

Belden forecasts Q2 revenue of $735M-$750M as it plans to acquire Ruckus for $1.85B

Smurfit Westrock expects Q2 adjusted EBITDA of $1.1B-$1.2B and reaffirms 2026 $5B-$5.3B outlook

Ranpak signals automation revenue near $60M in 2026 and reiterates path to surpass $100M

Standard Motor Products outlines 2026 adjusted EBITDA margin of 11% to 12% while targeting 2x leverage by year-end

Plexus anticipates mid-teens+ FY2026 revenue growth while forecasting $50M-$75M free cash flow

Phathom outlines $320M-$345M 2026 revenue as it targets operating profitability by Q3

Vanguard Target Maturity 2028 Corporate Bond ETF declares monthly distribution of $0.0721

Ametek forecasts 2026 EPS of $7.94 to $8.14 while raising organic sales outlook to mid-single digits

Newmark raises 2026 outlook to $3.775B-$3.875B in revenue and $1.87-$1.98 in adjusted EPS backed by a strong pipeline

Vanguard Target Maturity 2027 Corporate Bond ETF declares monthly distribution of $0.0817

Vanguard Core-Plus Bond Index ETF declares monthly distribution of $0.2730

Vanguard High-Yield Active ETF declares monthly distribution of $0.3649

Empire State Realty Trust targets 90%-92% year-end occupancy for 2026 while pushing debt maturities to 2028

Lilly projects 2026 revenue of $82B-$85B and non-GAAP EPS of $35.50-$37 as Foundayo launch begins

Whiskey makers may see some relief if the era of dueling tariffs is over

Cardinal Health outlines fiscal 2026 non-GAAP EPS of $10.70-$10.80 while raising adjusted free cash flow to $3.3B-$3.7B

Bill to fund DHS passes House, heads to president's desk

Cimpress projects at least $465m FY 2026 adjusted EBITDA and expects FY 2027 adjusted EBITDA growth in excess of 10%

Alerus expects 2026 net interest margin of ~3.55%-3.65% with mid-single-digit loan growth

VICI outlines 2026 AFFO of $2.44-$2.47 per share while raising full-year guidance

ONEOK cut at Scotiabank as less compelling value proposition vs. other liquids names

Novocure outlines $690M-$710M 2026 revenue guidance as Optune Pax launch reaches 169 prescriptions in 7 weeks

Kirby signals 2026 EPS up 5% to up 15% as inland pricing strengthens despite fuel and OEM timing headwinds

Hershey signals nearly 300 bps Q2 gross margin expansion while planning >500 bps lift in H2